Effect of Graft Type on Knee Muscle Strength After ACL Reconstruction
Condition(s) studied
Study summary
This prospective observational study will compare recovery after anterior cruciate ligament reconstruction using quadriceps tendon autograft or hamstring tendon autograft. The main goal is to examine differences in knee muscle strength recovery during the early and mid-term postoperative period. Participants aged 13 to 45 years who undergo unilateral ACL reconstruction and meet the eligibility criteria will be followed at Hacettepe University. Knee extensor and flexor strength will be assessed using isometric testing at postoperative weeks 4, 8, and 12 and month 6, and with isokinetic concentric testing at months 3 and 6. Functional outcomes and kinesiophobia will also be evaluated at month 6 using IKDC, KOOS, and the Tampa Scale for Kinesiophobia. All participants will receive the same standard postoperative rehabilitation program under physiotherapist supervision. The study aims to clarify whether graft type is associated with different patterns of muscle strength recovery and functional improvement after ACL reconstruction
Eligibility
Primary outcome measure(s)
- Isometric Quadriceps Muscle Strengt — Postoperative weeks 4, 8, and 12, and month 6
Maximum voluntary isometric quadriceps strength measured with an IsoMed 2000 dynamometer at 60° of knee flexion. The highest value from 3 maximal 5-second contractions will be recorded and normalized to body weight (Nm/kg). - Isometric Hamstring Muscle Strength — Postoperative weeks 4, 8, and 12, and month 6
Maximum voluntary isometric hamstring strength measured with an IsoMed 2000 dynamometer at 60° of knee flexion. The highest value from 3 maximal 5-second contractions will be recorded and normalized to body weight (Nm/kg)
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Hacettepe University | Ankara | Turkey (Türkiye) | Recruiting |
More Hacettepe University trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07523854 on ClinicalTrials.gov ↗ ← All trials in Turkey